Human CD4(+)CD25(+) cells: a naturally occurring population of regulatory T cells
- PMID: 11675346
- DOI: 10.1182/blood.v98.9.2736
Human CD4(+)CD25(+) cells: a naturally occurring population of regulatory T cells
Abstract
Despite thymic deletion of cells with specificity for self-antigens, autoreactive T cells are readily detectable in the normal T-cell repertoire. In recent years, a population of CD4(+) T cells that constitutively express the interleukin-2 receptor-alpha chain, CD25, has been shown to play a pivotal role in the maintenance of self-tolerance in rodent models. This study investigated whether such a regulatory population exists in humans. A population of CD4(+)CD25(+) T cells, taken from the peripheral blood of healthy individuals and phenotypically distinct from recently activated CD4(+) T cells, was characterized. These cells were hyporesponsive to conventional T-cell stimuli and capable of suppressing the responses of CD4(+)CD25(-) T cells in vitro. Addition of exogenous interleukin-2 abrogated the hyporesponsiveness and suppressive effects of CD4(+)CD25(+) cells. Suppression required cell-to-cell contact but did not appear to be via the inhibition of antigen-presenting cells. In addition, there were marked changes in the expression of Notch pathway molecules and their downstream signaling products at the transcriptional level, specifically in CD4(+)CD25(+) cells, suggesting that this family of molecules plays a role in the regulatory function of CD4(+)CD25(+) cells. Cells with similar phenotype and function were detected in umbilical venous blood from healthy newborn infants. These results suggest that CD4(+)CD25(+) cells represent a population of regulatory T cells that arise during fetal life. Comparison with rodent CD4(+)CD25(+) cells suggests that this population may play a key role in the prevention of autoimmune diseases in humans.
Similar articles
-
Thymus and autoimmunity: production of CD25+CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance.J Immunol. 1999 May 1;162(9):5317-26. J Immunol. 1999. PMID: 10228007
-
Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases.J Immunol. 1995 Aug 1;155(3):1151-64. J Immunol. 1995. PMID: 7636184
-
Naturally anergic and suppressive CD25(+)CD4(+) T cells as a functionally and phenotypically distinct immunoregulatory T cell subpopulation.Int Immunol. 2000 Aug;12(8):1145-55. doi: 10.1093/intimm/12.8.1145. Int Immunol. 2000. PMID: 10917889
-
Thymic commitment of regulatory T cells is a pathway of TCR-dependent selection that isolates repertoires undergoing positive or negative selection.Curr Top Microbiol Immunol. 2005;293:43-71. doi: 10.1007/3-540-27702-1_3. Curr Top Microbiol Immunol. 2005. PMID: 15981475 Review.
-
Human CD4+CD25+ regulatory T cells.Semin Immunol. 2004 Apr;16(2):89-98. doi: 10.1016/j.smim.2003.12.005. Semin Immunol. 2004. PMID: 15036232 Review.
Cited by
-
Modulation of T cell immune functions by the prostaglandin E(2) - cAMP pathway in chronic inflammatory states.Br J Pharmacol. 2012 May;166(2):411-9. doi: 10.1111/j.1476-5381.2011.01800.x. Br J Pharmacol. 2012. PMID: 22141738 Free PMC article. Review.
-
Cannabidiol, a non-psychoactive cannabinoid, leads to EGR2-dependent anergy in activated encephalitogenic T cells.J Neuroinflammation. 2015 Mar 15;12:52. doi: 10.1186/s12974-015-0273-0. J Neuroinflammation. 2015. PMID: 25880134 Free PMC article.
-
Multiple unit pooled umbilical cord blood is a viable source of therapeutic regulatory T cells.Transplantation. 2013 Jan 15;95(1):85-93. doi: 10.1097/TP.0b013e31827722ed. Transplantation. 2013. PMID: 23263503 Free PMC article.
-
Therapeutic opportunities for manipulating T(Reg) cells in autoimmunity and cancer.Nat Rev Drug Discov. 2013 Jan;12(1):51-63. doi: 10.1038/nrd3683. Nat Rev Drug Discov. 2013. PMID: 23274471 Review.
-
Flow cytometric analysis of expression of transforming growth factor-beta and glucocorticoid-induced tumor necrosis factor receptor on CD4(+) CD25(+) T cells of patients with inflammatory bowel disease.Dig Dis Sci. 2006 Jan;51(1):178-84. doi: 10.1007/s10620-006-3105-3. Dig Dis Sci. 2006. PMID: 16416233
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous